RedHill Biopharma (RDHL) Other Non Operating Income (2015 - 2016)
RedHill Biopharma's (RDHL) quarterly Other Non Operating Income came in at -$201000.0 in Q1 2016, up 18.95% year-over-year from -$168976.3 in Q2 2015, and up 18.95% quarter-over-quarter from -$248000.0 in Q1 2015.
Powered by 
Analysis
RedHill Biopharma (RDHL) Other Non Operating Income (2015 - 2016) Analysis & Trends
RedHill Biopharma (RDHL) has reported Other Non Operating Income for 2 consecutive years, with -$201000.0 the latest figure, recorded in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | -201,000.00 |
| Mar 31, 2015 | -248,000.00 |